Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 1 November 2024, 13:10 HKT/SGT
Share:
    

Source: JBM (Healthcare) Limited
JBM Healthcare Issues Positive Profit Alert
- Anticipates Not Less Than 50% Rise in Consolidated Profit Attributable to Shareholders

HONG KONG, Nov 1, 2024 - (ACN Newswire) - JBM (Healthcare) Limited (“JBM Healthcare” or the “Company”; Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, has today announced a positive profit alert. Based on a preliminary review of the unaudited consolidated management accounts of the Group for the six months ended 30 September 2024 and the information currently available to the board of directors of the Company, the Group expects to record an increase in the consolidated profit attributable to shareholders for the six months ended 30 September 2024 (“Consolidated Profit”) by not less than 50% as compared to that for the same period last year.

The significant increase in Consolidated Profit was primarily driven by the robust sales momentum of the Group’s key brands, notably Ho Chai Kung in the branded medicines segment and Po Chai Pills in the proprietary Chinese medicines segment. This was further supported by the sustained growth of the Group’s concentrated Chinese medicine granules business . This encouraging performance reflects the Group’s effective execution of sales and marketing strategies across both offline and online channels, capitalising on the growth potential of branded consumer healthcare products in the markets of Hong Kong, Macau and cities within the Greater Bay Area.

JBM Healthcare has a diversified portfolio spanning branded medicines, proprietary Chinese medicines, and health and wellness products. The Group continues to make progress on its strategic priorities, including expanding e-commerce platforms locally and cross-border, exploring opportunities in traditional Chinese medicines for Hong Kong and the Greater Bay Area, adapting its product mix to consumer trends, leveraging its brand management strengths, and enhancing commercial execution.

For details, please refer to the announcement on HKEX.

About JBM (Healthcare) Limited (Stock Code: 2161)

JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex, Mederma for Kids, Tong Tai Chung Woodlok Oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling Oil and Konsodona Medicated Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk




Topic: Press release summary
Source: JBM (Healthcare) Limited

Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



JBM (Healthcare) Limited
June 18, 2024 19:00 HKT/SGT
JBM Healthcare Announces FY2024 Annual Results
May 5, 2024 11:00 HKT/SGT
JBM Healthcare Issues Positive Profit Alert
Nov 22, 2023 19:50 HKT/SGT
JBM Healthcare Announces FY2024 Interim Results
June 15, 2023 23:40 HKT/SGT
JBM Healthcare Announces FY2023 Annual Results
Nov 25, 2022 23:25 HKT/SGT
JBM Healthcare Announces FY2023 Interim Results
June 15, 2022 19:56 HKT/SGT
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia
June 29, 2021 22:55 HKT/SGT
JBM Healthcare Announces FY2021 Annual Results
Feb 5, 2021 16:28 HKT/SGT
JBM (Healthcare) Limited Debuts on The Main Board of SEHK
Jan 25, 2021 17:20 HKT/SGT
JBM (Healthcare) Limited to Be Spun Off from Jacobson Pharma Corporation Limited
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: